- Home
- NERV vs HYFM Comparison
NERV vs HYFM Comparison
Compare NERV & HYFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- HYFM
- Stock Information
- Founded
- NERV 2007
- HYFM 1977
- Country
- NERV United States
- HYFM United States
- Employees
- NERV N/A
- HYFM N/A
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- HYFM Industrial Machinery/Components
- Sector
- NERV Health Care
- HYFM Industrials
- Exchange
- NERV Nasdaq
- HYFM Nasdaq
- Market Cap
- NERV 14.6M
- HYFM 11.2M
- IPO Year
- NERV 2014
- HYFM 2020
- Fundamental
- Price
- NERV $3.73
- HYFM $2.21
- Analyst Decision
- NERV Hold
- HYFM
- Analyst Count
- NERV 1
- HYFM 0
- Target Price
- NERV $4.00
- HYFM N/A
- AVG Volume (30 Days)
- NERV 8.7M
- HYFM 27.1K
- Earning Date
- NERV 11-05-2025
- HYFM 11-07-2025
- Dividend Yield
- NERV N/A
- HYFM N/A
- EPS Growth
- NERV N/A
- HYFM N/A
- EPS
- NERV N/A
- HYFM N/A
- Revenue
- NERV N/A
- HYFM $161,102,000.00
- Revenue This Year
- NERV N/A
- HYFM N/A
- Revenue Next Year
- NERV N/A
- HYFM $37.86
- P/E Ratio
- NERV N/A
- HYFM N/A
- Revenue Growth
- NERV N/A
- HYFM N/A
- 52 Week Low
- NERV $1.15
- HYFM $1.50
- 52 Week High
- NERV $12.46
- HYFM $8.55
- Technical
- Relative Strength Index (RSI)
- NERV 51.45
- HYFM 33.36
- Support Level
- NERV $3.50
- HYFM $2.22
- Resistance Level
- NERV $4.00
- HYFM $2.54
- Average True Range (ATR)
- NERV 0.95
- HYFM 0.20
- MACD
- NERV -0.13
- HYFM -0.02
- Stochastic Oscillator
- NERV 11.92
- HYFM 3.53
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About HYFM Hydrofarm Holdings Group Inc.
Hydrofarm Holdings Group Inc is a distributor and manufacturer of agriculture equipment and supplies. Some of its products includes lighting solutions, growing media (i.e., premium soils and soil alternatives), nutrients, equipment, and supplies sold under proprietary, exclusive/preferred brands, or non-exclusive/distributed brands. The business is organized into two operating segments, the U.S. and Canada.